Private equity investor firm Royalty Pharma has acquired a royalty interest in Amgen’s Imdelltra (tarlatamab-dlle) from BeOne Medicines (formerly known...
Private equity investor firm Royalty Pharma has acquired a royalty interest in Amgen’s Imdelltra (tarlatamab-dlle) from BeOne Medicines (formerly known...